arrow
S

Scott G. Franzblau

university of illinois at chicago
H指数:77
被引数:2.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Biological Evaluation of Esters of 4-Carboxylate-1,2,3-triazine and Analogs as New Potential Anti-Mycobacterium tuberculosis Agents

4-羧酸酯-1,2,3-三嗪及其类似物的生物评价:作为新型潜在抗分枝杆菌结核病剂的潜力

2026-06-070
OA
Advancing the antituberculosis activity of nitropicolinic acids and amides

推进硝基吡嗪甲酸及其酰胺的抗结核活性

2025-10-290
OAAI
Nifuroxazide and 4-Hydroxybenzhydrazone Derivatives as New Antiparasitic (Trypanosoma cruzi and Leishmania mexicana) and Anti-Mycobacterium tuberculosis Agents

呋喃唑酮及其4-羟基苯肼盐衍生物作为新的抗寄生虫(克氏锥虫和墨西哥利什曼原虫)和抗分枝杆菌结核分枝杆菌剂

2025-05-070
OA
Expanding the Landscape of Dual Action Antifolate Antibacterials through 2,4-Diamino-1,6-dihydro-1,3,5-triazines
2025-02-140
PRE
Discovery of New Cyclic Lipodepsipeptide Orfamide N via Partnership with Middle School Students from the Boys and Girls Club
2024-10-240
OAAI
Cavomycins A-C, Linear Oligomer Depsipeptides from an Annelid-Associated Streptomyces cavourensis

Cavomycins a-c,来自与链状链霉菌相关的链霉菌的线性低聚物缩肽

2024-03-041
PRE
Expanding the chemical space of ester of quinoxaline-7-carboxylate 1,4-di-N-oxide derivatives as potential antitubercular agents

扩大quinoxaline-7-carboxylate 1,4-二-n-氧化物衍生物的酯作为潜在抗结核药的化学空间

2024-01-010
PRE
Nitroimidazopyrazinones with Oral Activity against Tuberculosis and Chagas Disease in Mouse Models of Infection

在小鼠感染模型中具有口服抗结核和查加斯病活性的硝基咪唑并吡嗪酮

2022-09-166
OA